Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Poppe

Showing results (111-120 of 118) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 118 results.
European Journal of Heart Failure|September 12, 2015
Is heart rate a risk marker in patients with chronic heart failure and concomitant atrial fibrillation? Results from the MAGGIC meta-analysisJoanne Simpson, Davide Castagno, Rob N Doughty, et al.
QJM : Monthly Journal of the Association of Physicians|May 17, 2015
Prognostic significance of anaemia in patients with heart failure with preserved and reduced ejection fraction: results from the MAGGIC individual patient data meta-analysisC Berry, K K Poppe, G D Gamble, et al.
Journal of the American Heart Association|April 19, 2024
Longitudinal NT-proBNP: Associations With Echocardiographic Changes and Outcomes in Heart FailureKanako Teramoto, Wan Ting Tay, Jasper Tromp, et al.
The New Zealand Medical Journal|July 18, 2024
ANZACS-QI Heart Failure Registry: a new approach using age-stratified sampling of hospital discharges to guide quality improvement (ANZACS-QI 79)Daniel Zl Chan, Robert N Doughty, Mayanna Lund, et al.
European Heart Journal|January 25, 2015
Differing prognostic value of pulse pressure in patients with heart failure with reduced or preserved ejection fraction: results from the MAGGIC individual patient meta-analysisColette E Jackson, Davide Castagno, Aldo P Maggioni, et al.
Plos One|March 4, 2021
Presence of antibody-dependent cellular cytotoxicity (ADCC) against SARS-CoV-2 in COVID-19 plasmaFor Yue Tso, Salum J Lidenge, Lisa K Poppe, et al.
Heart (British Cardiac Society)|February 14, 2023
Prognostic modelling of clinical outcomes after first-time acute coronary syndrome in New ZealandNikki J Earle, Katrina K Poppe, Anna Rolleston, et al.
Atherosclerosis|September 17, 2025
Lipoprotein(a) concentrations and secondary outcomes following first-time acute coronary syndrome: The Multi-Ethnic New Zealand Study of Acute Coronary Syndromes (MENZACS)Malcolm E Legget, Nikki J Earle, Katrina K Poppe, et al.
Pageof 12

Showing results (111-120 of 118) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 118 results.
European Journal of Heart Failure|September 12, 2015
Is heart rate a risk marker in patients with chronic heart failure and concomitant atrial fibrillation? Results from the MAGGIC meta-analysisJoanne Simpson, Davide Castagno, Rob N Doughty, et al.
QJM : Monthly Journal of the Association of Physicians|May 17, 2015
Prognostic significance of anaemia in patients with heart failure with preserved and reduced ejection fraction: results from the MAGGIC individual patient data meta-analysisC Berry, K K Poppe, G D Gamble, et al.
Journal of the American Heart Association|April 19, 2024
Longitudinal NT-proBNP: Associations With Echocardiographic Changes and Outcomes in Heart FailureKanako Teramoto, Wan Ting Tay, Jasper Tromp, et al.
The New Zealand Medical Journal|July 18, 2024
ANZACS-QI Heart Failure Registry: a new approach using age-stratified sampling of hospital discharges to guide quality improvement (ANZACS-QI 79)Daniel Zl Chan, Robert N Doughty, Mayanna Lund, et al.
European Heart Journal|January 25, 2015
Differing prognostic value of pulse pressure in patients with heart failure with reduced or preserved ejection fraction: results from the MAGGIC individual patient meta-analysisColette E Jackson, Davide Castagno, Aldo P Maggioni, et al.
Plos One|March 4, 2021
Presence of antibody-dependent cellular cytotoxicity (ADCC) against SARS-CoV-2 in COVID-19 plasmaFor Yue Tso, Salum J Lidenge, Lisa K Poppe, et al.
Heart (British Cardiac Society)|February 14, 2023
Prognostic modelling of clinical outcomes after first-time acute coronary syndrome in New ZealandNikki J Earle, Katrina K Poppe, Anna Rolleston, et al.
Atherosclerosis|September 17, 2025
Lipoprotein(a) concentrations and secondary outcomes following first-time acute coronary syndrome: The Multi-Ethnic New Zealand Study of Acute Coronary Syndromes (MENZACS)Malcolm E Legget, Nikki J Earle, Katrina K Poppe, et al.
Pageof 12